t-bet gradient controls fate function ccr6-ror gamma t+ innate lymphoid cells 
mucosal surfaces immune system initiate inflammatory immune responses plethora antigens constantly present environment remain poised unleash potent assault intestinal pathogens transcriptional programs regulatory factors required immune cells switch homeostatic often tissue-protective function1 potent antimicrobial immunity poorly defined mucosal retinoic-acidreceptor-related orphan receptor-gamma t-positive ror gamma t+ innate lymphoid cells ilcs emerging important innate lymphocyte population required immunity intestinal infections2 various subsets ror gamma t+ ilcs described3- transcriptional programs controlling specification fate remain largely unknown provide evidence transcription factor t-bet determines fate distinct lineage ccr6-ror gamma t+ ilcs postnatally emerging ccr6-ror gamma t+ ilcs upregulated t-bet controlled cues commensal microbiota interleukin- il- contrast ccr6+ror gamma t+ ilcs arise earlier ontogeny express t-bet t-bet instructed expression t-bet target genes interferon-gamma ifn-gamma natural cytotoxicity receptor nkp46 mice genetically lacking t-bet showed normal development ccr6-ror gamma t+ ilcs differentiate nkp46-expressing ror gamma t+ ilcs il--producing natural killer nk- cells39 failed produce ifn-gamma production ifn-gamma t-bet-expressing ccr6-ror gamma t+ ilcs essential release mucus-forming glycoproteins required protect epithelial barrier salmonella enterica infection1011 salmonella infection also causes severe enterocolitis least partly driven ifn-gamma12 mice deficient t-bet depleted ilcs developed mild enterocolitis thus graded expression t-bet ccr6-ror gamma t+ mcs facilitates differentiation ifn-gamma-producing ccr6-ror gamma t+ ilcs required protect epithelial barrier salmonella infections co-expression t-bet ror gamma t also found subsets il--producing t-helper th17 cells13 may evolutionarily conserved transcriptional program originally developed part innate defence infections also confers increased risk immune-mediated pathology 
